{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:05:34Z","timestamp":1777950334342,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI145045IH"],"award-info":[{"award-number":["1R01AI145045IH"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003180","name":"Amsterdam UMC Location AMC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115046","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T05:01:34Z","timestamp":1687928494000},"page":"115046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-5479","authenticated-orcid":false,"given":"Minghui","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanling","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Herrera-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2023.115046_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2015-000010","article-title":"Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades","volume":"1","author":"Levi","year":"2016","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.biopha.2023.115046_bib2","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. Geneva: World Health Organization. Copyright \u00a9 2010, World Health Organization.; 2010."},{"issue":"6271","key":"10.1016\/j.biopha.2023.115046_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.aad5177","article-title":"In vivo gene editing in dystrophic mouse muscle and muscle stem cells","volume":"351","author":"Tabebordbar","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2023.115046_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm.4170","article-title":"A genome-editing strategy to treat \u03b2-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition","volume":"22","author":"Traxler","year":"2016","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."},{"issue":"7601","key":"10.1016\/j.biopha.2023.115046_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2023.115046_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12981-022-00483-y","article-title":"CRISPR\/Cas9: a tool to eradicate HIV-1","volume":"19","author":"Bhowmik","year":"2022","journal-title":"AIDS Res Ther."},{"key":"10.1016\/j.biopha.2023.115046_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175173","article-title":"Treatment strategies for HIV infection with emphasis on role of CRISPR\/Cas9 gene: Success so far and road ahead","volume":"931","author":"Jena","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biotech11030025","article-title":"Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV","volume":"11","author":"Freen-van Heeren","year":"2022","journal-title":"BioTech"},{"key":"10.1016\/j.biopha.2023.115046_bib10","first-page":"3","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","author":"Ebina","year":"2013","journal-title":"Sci. Rep. -Uk"},{"key":"10.1016\/j.biopha.2023.115046_bib11","first-page":"6","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115046_bib12","doi-asserted-by":"crossref","first-page":"31527","DOI":"10.1038\/srep31527","article-title":"Negative feedback regulation of HIV-1 by gene editing strategy","volume":"6","author":"Kaminski","year":"2016","journal-title":"Sci. Rep."},{"issue":"6213","key":"10.1016\/j.biopha.2023.115046_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"issue":"6166","key":"10.1016\/j.biopha.2023.115046_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2023.115046_bib15","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115046_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41421-018-0069-3","article-title":"Repurposing CRISPR-Cas12b for mammalian genome engineering","volume":"4","author":"Teng","year":"2018","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.biopha.2023.115046_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41467-018-08224-4","article-title":"Engineering of CRISPR-Cas12b for human genome editing","volume":"10","author":"Strecker","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2023.115046_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/15476286.2018.1495492","article-title":"Defining the seed sequence of the Cas12b CRISPR-Cas effector complex","volume":"16","author":"Jain","year":"2019","journal-title":"RNA Biol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115046_bib20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2016.11.040","article-title":"C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism","volume":"65","author":"Liu","year":"2017","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models","volume":"25","author":"Yin","year":"2017","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2023.115046_bib22","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.celrep.2016.03.042","article-title":"CRISPR\/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escape","volume":"15","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.biopha.2023.115046_bib24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1089\/hum.2018.018","article-title":"CRISPR\/Cas9 inhibits multiple steps of HIV-1 infection","volume":"29","author":"Yin","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.biopha.2023.115046_bib25","article-title":"HIV excision utilizing CRISPR\/Cas9 technology: attacking the proviral quasispecies in reservoirs to achieve a cure","volume":"1","author":"Dampier","year":"2014","journal-title":"MOJ Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115046_bib26","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","article-title":"A combinatorial CRISPR-Cas9 attack on HIV-1 DNA extinguishes all infectious provirus in infected T cell cultures","volume":"17","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2016.24","article-title":"CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115046_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.115046_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nbt.3737","article-title":"Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array","volume":"35","author":"Zetsche","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115046_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1080\/15476286.2018.1551703","article-title":"Improvement of the CRISPR-Cpf1 system with ribozyme-processed crRNA","volume":"15","author":"Gao","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.biopha.2023.115046_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-3067-8_3","article-title":"Transcriptional regulation with CRISPR\/Cas9 effectors in mammalian cells","volume":"1358","author":"Pham","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2023.115046_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.omtn.2018.10.016","article-title":"A single H1 promoter can drive both guide RNA and endonuclease expression in the CRISPR-Cas9 system","volume":"14","author":"Gao","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.biopha.2023.115046_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jviromet.2014.03.021","article-title":"The search for a T cell line for testing novel antiviral strategies against HIV-1 isolates of diverse receptor tropism and subtype origin","volume":"203","author":"Herrera-Carrillo","year":"2014","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrmicro.2016.184","article-title":"Diversity and evolution of class 2 CRISPR-Cas systems","volume":"15","author":"Shmakov","year":"2017","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.biopha.2023.115046_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jbiotec.2015.06.427","article-title":"Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity","volume":"211","author":"Anderson","year":"2015","journal-title":"J. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115046_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115046_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v11030255","article-title":"The impact of HIV-1 genetic diversity on CRISPR-Cas9 antiviral activity and viral escape","volume":"11","author":"Darcis","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.biopha.2023.115046_bib39","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JVI.02035-07","article-title":"Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference","volume":"82","author":"von Eije","year":"2008","journal-title":"J. Virol."},{"issue":"8\u20139","key":"10.1016\/j.biopha.2023.115046_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/gt.2016.41","article-title":"Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study","volume":"23","author":"Kaminski","year":"2016","journal-title":"Gene Ther."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.115046_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.cr.7290370","article-title":"Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions","volume":"15","author":"Li","year":"2005","journal-title":"Cell Res"},{"issue":"11","key":"10.1016\/j.biopha.2023.115046_bib42","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1091\/mbc.e11-11-0928","article-title":"An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I","volume":"23","author":"Dikeakos","year":"2012","journal-title":"Mol. Biol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2023.115046_bib43","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0092-8674(91)90097-I","article-title":"Importance of the nef gene for maintenance of high virus loads and for development of AIDS","volume":"65","author":"Kestler","year":"1991","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2023.115046_bib44","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ejcb.2010.09.010","article-title":"Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse","volume":"90","author":"Haller","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115046_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-4690-10-80","article-title":"HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer","volume":"10","author":"Malbec","year":"2013","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115046_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1084\/jem.179.1.115","article-title":"The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes","volume":"179","author":"Spina","year":"1994","journal-title":"J. Exp. Med"},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1073\/pnas.84.5.1434","article-title":"Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication","volume":"84","author":"Luciw","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4872","key":"10.1016\/j.biopha.2023.115046_bib48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.3262235","article-title":"Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR","volume":"241","author":"Ahmad","year":"1988","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.biopha.2023.115046_bib49","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JVI.75.7.3495-3500.2001","article-title":"Repair of a rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site","volume":"75","author":"Verhoef","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.115046_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virusres.2018.04.008","article-title":"The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012","volume":"250","author":"van der Kuyl","year":"2018","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.biopha.2023.115046_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/dvg.22915","article-title":"Chromosome engineering in zygotes with CRISPR\/Cas9","volume":"54","author":"Boroviak","year":"2016","journal-title":"Genesis"},{"issue":"6","key":"10.1016\/j.biopha.2023.115046_bib52","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1074\/jbc.A114.564625","article-title":"Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)\/Cas9 nuclease system in mammalian cells","volume":"292","author":"Canver","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/v12030330","article-title":"CRISPR-Cas9 dual-gRNA attack causes mutation, excision and inversion of the HIV-1 proviral DNA","volume":"12","author":"Binda","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.biopha.2023.115046_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2005.07.023","article-title":"The role of upstream U3 sequences in HIV-1 replication and CD4+ T cell depletion in human lymphoid tissue ex vivo","volume":"341","author":"Munch","year":"2005","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2023.115046_bib55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/aid.1994.10.343","article-title":"Construction and in vitro properties of HIV-1 mutants with deletions in \"nonessential\" genes","volume":"10","author":"Gibbs","year":"1994","journal-title":"AIDS Res Hum. Retrovir."},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/dna.1992.11.369","article-title":"Structure-function studies of HIV-1: influence of long terminal repeat U3 region sequences on virus production","volume":"11","author":"Velpandi","year":"1992","journal-title":"DNA Cell Biol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115046_bib57","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1007\/s11033-014-3456-3","article-title":"Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells","volume":"41","author":"Qu","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2023.115046_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1742-4682-8-26","article-title":"Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapy","volume":"8","author":"Wayengera","year":"2011","journal-title":"Theor. Biol. Med Model"},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125652","article-title":"Damaging the Integrated HIV Proviral DNA with TALENs","volume":"10","author":"Strong","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2023.115046_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nmeth.1670","article-title":"Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection","volume":"8","author":"Pattanayak","year":"2011","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.biopha.2023.115046_bib61","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.biopha.2023.115046_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/hum.2017.047","article-title":"Comparison of zinc finger nucleases versus CRISPR-specific nucleases for genome editing of the Wiskott-Aldrich syndrome locus","volume":"29","author":"Gutierrez-Guerrero","year":"2018","journal-title":"Hum. Gene Ther."},{"issue":"47","key":"10.1016\/j.biopha.2023.115046_bib63","doi-asserted-by":"crossref","first-page":"24377","DOI":"10.1074\/jbc.M116.752329","article-title":"Different DNA end configurations dictate which NHEJ components are most important for joining efficiency","volume":"291","author":"Chang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115046_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2023.115046_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omtm.2022.02.010","article-title":"A combinatorial CRISPR-Cas12a attack on HIV DNA","volume":"25","author":"Fan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"6501","key":"10.1016\/j.biopha.2023.115046_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb1400","article-title":"CRISPR-Cas Phi from huge phages is a hypercompact genome editor","volume":"369","author":"Pausch","year":"2020","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biopha.2023.115046_bib67","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41589-021-00868-6","article-title":"Programmed genome editing by a miniature CRISPR-Cas12f nuclease","volume":"17","author":"Wu","year":"2021","journal-title":"Nat. Chem. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223008363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:00:45Z","timestamp":1777878045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223008363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":67,"alternative-id":["S0753332223008363"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115046","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115046"}}